Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regeneration of Posterior Cruciate Ligament Injury Using Hypoxia Conditioned Allogenic Adipose Mesenchymal Stem Cell (AdMSC) and Ligament Derived Condition Medium (Secretome)

NCT04889963 is registered in ClinicalTrials.gov with Gadjah Mada University as lead sponsor.

NCT NCT04889963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04889963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regeneration of Posterior Cruciate Ligament Injury Using Hypoxia Conditioned Allogenic Adipose Mesenchymal Stem Cell (AdMSC) and Ligament Derived Condition Medium (Secretome)
Lead sponsor
Gadjah Mada University
Phase
Phase 1
Overall status
Unknown status
Start date
January 1, 2021
Completion date
June 30, 2021
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adypose mesenchimal stem cell, ligament derived conditined medium, ligament rupture